Skip to main content
Top
Published in: Breast Cancer Research 3/2002

01-06-2002 | Book report

Nass SJ, Henderson IC, Lashof JC (eds): Mammography and Beyond: Developing Technologies for Early Detection of Breast Cancer. Washington, DC: National Academy Press, 2001. 316 pp.

ISBN 0-309-07283-2

Author: Eugenio Paci

Published in: Breast Cancer Research | Issue 3/2002

Login to get access

Excerpt

Publication of this report from the Committee on Technologies for the Early Detection of Breast Cancer, chaired by JC Lashof and I Craig Henderson (vice chair), is timely and important. The Institute of Medicine Committee assembled a 16-member interdisciplinary group, and the contributions included in the book reflect this wide-angle approach to the problem. Each specialist may find less than he or she would like, but I found many interesting details that are useful for gaining a general understanding of the technological future of breast cancer screening. Imaging technology is examined within the context of the complex natural history of breast cancer; advances in current understanding of genetic and biological issues, and in therapeutic approaches are less briefly, but exhaustively, presented. …
Literature
1.
go back to reference Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001, 93: 1054-1060. 10.1093/jnci/93.14.1054.CrossRefPubMed Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001, 93: 1054-1060. 10.1093/jnci/93.14.1054.CrossRefPubMed
Metadata
Title
Nass SJ, Henderson IC, Lashof JC (eds): Mammography and Beyond: Developing Technologies for Early Detection of Breast Cancer. Washington, DC: National Academy Press, 2001. 316 pp.
ISBN 0-309-07283-2
Author
Eugenio Paci
Publication date
01-06-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 3/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr429

Other articles of this Issue 3/2002

Breast Cancer Research 3/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine